Emmes: launch of rare disease center
Contract research organization Emmes is launching Orphan Reach, its new center geared toward advancing rare disease research. The center shares its name with the specialty CRO the company acquired in May 2021.
Emmes chief research officer Traci Clemons said, “Collectively, we have an incredibly strong team, bringing together deep global rare disease clinical operations capabilities with extensive scientific research experience across multiple rare disease indications. In areas such as ophthalmology, metabolic disorders, and gene therapies, Emmes has data and analytical origins spanning over four decades and a wealth of scientific publications.”